Can Early Cholesterol Lowering Prevent Heart Attacks in Diabetics?
Early cholesterol lowering with evolocumab significantly reduces first heart attack and stroke risk in high-risk diabetics Can heart attacks and strokes be prevented before they even start? Emerging research suggests the answer may be yes—especially for people with diabetes. A growing body of evidence shows that aggressively lowering cholesterol early, even before visible artery disease develops, could dramatically reduce cardiovascular risk. In this article, we explore how intensive cholesterol lowering works, the role of evolocumab, and why early intervention may transform preventive care for millions of high-risk individuals. Understanding the Link Between Diabetes and Heart Disease Diabetes is more than a blood sugar disorder—it significantly increases the risk of cardiovascular disease. People with diabetes are up to two to four times more likely to develop heart disease compared to those without it. This elevated risk is driven by several factors: Chronic infl...